NCT05958199 2025-06-27A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NextPoint Therapeutics, Inc.Phase 1 Suspended131 enrolled
NCT04714983 2024-04-09DNX-2440 for Resectable Colorectal Liver MetastasisDNAtrix, Inc.Phase 1 Suspended30 enrolled
NCT00065572 2011-01-26Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)AstraZenecaPhase 2 Suspended
NCT00033956 2005-06-24Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2MetaPhore PharmaceuticalsPhase 1/2 Suspended48 enrolled